Journal
/
/
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
DOI:

10:46 min

September 13, 2022

, , , , ,

Chapters

  • 00:05Introduction
  • 01:02Binding Assay
  • 04:10Flow Cytometry and Data Analysis
  • 08:58Results: Flow Cytometric-Based Assay to Study the Binding of an Aptamer and Cancer Cells
  • 09:55Conclusion

Summary

Automatic Translation

A necessary step in anticancer aptamer development is to test its binding to the target. We demonstrate a flow cytometric-based assay to study this binding, emphasizing the importance of including a negative control aptamer and cancer cells that are positive or negative for that particular protein. 

Related Videos

Read Article